Get the app
US › Healthcare

Niki BioSolutions, Inc. (NIKI)

US · Healthcare · Biotechnology

$5.26+10.27%
Last close · 2026-09-17

Latest quarter · ended 2025-12-31

Revenue
$0
Net profit
$-307,495
Profit YoY
-111.6%
EPS
$-0.38

Key statistics

Market cap
$4.7M
Forward P/E
0.0
P/B
0.23
Book value
$26.75
EPS (TTM)
$-2.66
52-week high
$25.90
52-week low
$5.68
50-day MA
$8.11
200-day MA
$9.20
Beta
-0.90

Shareholding

Insiders
47.50%
Institutions
0.28%

Largest institutional holders

FundStake
Citadel Advisors Llc1.13%
Susquehanna International Group, LLP0.21%
XTX Topco Ltd0.18%
Morgan Stanley - Brokerage Accounts0.16%
Renaissance Technologies Corp0.15%
Advisor Group Holdings, Inc.0.07%
UBS Group AG0.02%
SBI Securities Co Ltd0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Niki BioSolutions, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.